The stakes

are pretty high, theoretically, for a psychedelic treatment, right? It's going to be a high cost, almost in a sense, a little bit like a surgery.

You've got this room for you for the day.

We're going to have some number of people dedicated to your treatment that day, you're probably going to get kind of one shot at it.

I mean, there might be in the Comp360 data, there's a second treatment, which could be helpful, but, you know, like it kind of needs to go well, right? And there's some suggestion and some data out there that patients that had a negative experience during their drug experience may not have the same response, chance for response or remission.

And so that means if that's true, and I don't know that we know that's 100% true, but if that ends up being true, then the onus on the clinic to provide the greatest amount of psychological safety possible for that person in their clinic is seems to be not only just good from a, you know, patient experience, customer experience standpoint, but may actually be like critical to or at least an important covariate in determining the ultimate outcome of the treatment.

That raises it to a very high level of importance potentially.

How will you handle patients who come to you specifically seeking the therapy?